StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
33
Publishing Date
2024 - 04 - 09
41
2024 - 03 - 06
37
2024 - 03 - 05
44
2024 - 02 - 27
37
2024 - 01 - 08
48
2024 - 01 - 04
47
2024 - 01 - 03
40
2024 - 01 - 02
42
2023 - 11 - 13
42
2023 - 11 - 09
63
2023 - 11 - 07
53
2023 - 11 - 06
45
2023 - 11 - 02
49
2023 - 11 - 01
60
2023 - 10 - 31
46
2023 - 10 - 30
38
2023 - 10 - 04
49
2023 - 09 - 11
38
2023 - 09 - 07
37
2023 - 09 - 06
52
2023 - 09 - 05
62
2023 - 08 - 14
41
2023 - 08 - 10
42
2023 - 08 - 08
38
2023 - 08 - 03
43
2023 - 06 - 01
56
2023 - 05 - 15
44
2023 - 05 - 11
59
2023 - 05 - 10
38
2023 - 05 - 09
46
2023 - 05 - 04
46
2023 - 05 - 02
40
2023 - 05 - 01
37
2023 - 04 - 27
37
2023 - 03 - 15
42
2023 - 03 - 07
48
2023 - 03 - 06
41
2023 - 03 - 01
47
2023 - 02 - 28
38
2022 - 11 - 14
38
2022 - 11 - 10
44
2022 - 11 - 03
45
2022 - 03 - 08
37
2022 - 03 - 01
45
2022 - 01 - 04
40
2021 - 12 - 13
42
2021 - 11 - 15
42
2021 - 11 - 12
41
2021 - 11 - 10
46
2021 - 11 - 09
44
2021 - 11 - 04
40
2021 - 10 - 07
40
2021 - 09 - 13
40
2021 - 09 - 07
40
2021 - 08 - 12
36
2021 - 08 - 05
36
2021 - 05 - 06
36
2021 - 04 - 27
41
2021 - 03 - 11
38
2021 - 03 - 04
42
Sector
Finance
1
Health services
1
Health technology
29
Professional, scientific, and technical services
2
Tags
Alliances
1
Application
1
Biocanada
1
Biocapital
1
Biomidwest
1
Biotech
1
Cancer
2
Ceo
1
Clearance
1
Clinical-trials-phase-ii
1
Conference
4
Covid
1
Covid-19
1
Disease
1
Events
2
Fda
1
Fda clearance
1
Financial results
8
Galectin-3
1
Genetown
1
Greco-1
1
Infectious disease
1
Iot
1
Ketamine
1
Lenzilumab
1
Leo
1
Lung cancer
1
N/a
21
Pancreas
1
Pancreatic
1
Pharmaceutical
1
Phase 1
1
Phase 2
3
Phase 2/3
1
Phase 2b
1
Phase 3
1
Positive
1
Presentation
1
Product-news
3
Research
1
Results
8
Security
1
Stroke
1
Therapeutics
1
Topline
1
Trial
3
Entities
Abbott laboratories
1
Acer therapeutics inc.
1
Aclaris therapeutics, inc.
2
Adc therapeutics sa
1
Addex therapeutics ltd
1
Black diamond therapeutics, inc.
1
Cerevel therapeutics holdings, inc.
1
Checkpoint therapeutics, inc.
1
Cyclo therapeutics inc - class a
1
Davita inc.
1
Diamedica therapeutics inc.
1
Esperion therapeutics, inc.
1
F-star therapeutics inc.
1
Fate therapeutics, inc.
5
Foghorn therapeutics inc.
1
Forma therapeutics holdings, inc.
1
Fortress biotech, inc.
1
G1 therapeutics, inc.
1
Gain therapeutics inc
1
Galectin therapeutics inc.
1
Galera therapeutics, inc.
1
Humanigen, inc.
1
Liminal biosciences inc.
1
Mustang bio, inc.
1
Onconova therapeutics, inc.
1
Sanofi
1
Seelos therapeutics, inc.
1
Spero therapeutics, inc.
1
Summit therapeutics inc.
1
Turning point therapeutics, inc.
1
Vyne therapeutics inc.
1
Symbols
ABT
1
ACER
1
ACRS
2
ADCT
1
ADXN
1
BDTX
1
CERE
1
CKPT
1
CYTH
1
DMAC
1
DVA
1
ESPR
1
FATE
5
FBIO
1
FHTX
1
FMTX
1
FSTX
1
GALT
1
GANX
1
GRTX
1
GTHX
1
HGEN
1
LMNL
1
MBIO
1
ONTX
1
SEEL
1
SMMT
1
SNY
1
SPRO
1
TPTX
1
VYNE
1
Exchanges
Nasdaq
30
Nyse
3
Crawled Date
2021 - 05 - 17
33
Crawled Time
01:00
1
06:00
1
11:00
3
12:00
8
12:15
1
13:00
5
13:15
5
19:00
5
20:00
1
21:00
2
23:00
1
Source
ir.stockpr.com
1
www.acertx.com
1
www.biospace.com
12
www.fatetherapeutics.com
5
www.globenewswire.com
12
www.prnewswire.com
1
www.vynetherapeutics.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
therapeutics
publishing date :
2021 - 05 - 17
save search
Onconova Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Update
Published:
2021-05-17
(Crawled : 23:00)
- globenewswire.com
ONTX
|
$0.9953
-5.61%
1.3M
|
Health Technology
|
-89.19%
|
O:
28.36%
H:
38.89%
C:
36.36%
financial results
results
Gain Therapeutics to Participate in Upcoming Virtual Investor Conferences in May
Published:
2021-05-17
(Crawled : 21:00)
- biospace.com/
GANX
|
$3.14
-0.63%
-0.64%
81K
|
Professional, Scientific, and T...
|
-66.91%
|
O:
0.0%
H:
1.97%
C:
1.84%
conference
Acer Therapeutics Reports Q1 2021 Financial Results and Provides Corporate Update
Published:
2021-05-17
(Crawled : 21:00)
- acertx.com
ACER
|
$0.9
-3.61%
420K
|
Health Technology
|
-66.42%
|
O:
1.87%
H:
4.76%
C:
-0.37%
financial results
results
Spero Therapeutics Awarded up to $23 Million by the National Institute of Allergy and Infectious Diseases to Support the Development of SPR206
Published:
2021-05-17
(Crawled : 20:00)
- globenewswire.com
SPRO
|
$1.5
2.04%
2.0%
210K
|
Health Technology
|
-88.81%
|
O:
0.52%
H:
6.83%
C:
2.45%
disease
infectious disease
515SM, Associate Scientist / Senior Research Associate, Bioassay Development
Published:
2021-05-17
(Crawled : 19:00)
- fatetherapeutics.com
FATE
|
$5.28
-1.86%
-1.89%
2.1M
|
Health Technology
|
-92.95%
|
O:
1.01%
H:
7.41%
C:
1.19%
research
516LF, Scientist / Associate Scientist, Cellular Reprogramming & Engineering
Published:
2021-05-17
(Crawled : 19:00)
- fatetherapeutics.com
FATE
|
$5.28
-1.86%
-1.89%
2.1M
|
Health Technology
|
-92.95%
|
O:
1.01%
H:
7.41%
C:
1.19%
517KY, Scientist, Process Development
Published:
2021-05-17
(Crawled : 19:00)
- fatetherapeutics.com
FATE
|
$5.28
-1.86%
-1.89%
2.1M
|
Health Technology
|
-92.95%
|
O:
1.01%
H:
7.41%
C:
1.19%
518SM, Information Security Engineer
Published:
2021-05-17
(Crawled : 19:00)
- fatetherapeutics.com
FATE
|
$5.28
-1.86%
-1.89%
2.1M
|
Health Technology
|
-92.95%
|
O:
1.01%
H:
7.41%
C:
1.19%
security
519SR, Shipping and Receiving Associate
Published:
2021-05-17
(Crawled : 19:00)
- fatetherapeutics.com
FATE
|
$5.28
-1.86%
-1.89%
2.1M
|
Health Technology
|
-92.95%
|
O:
1.01%
H:
7.41%
C:
1.19%
Cyclo Therapeutics Provides Business Update and Reports First Quarter 2021 Financial Results
Published:
2021-05-17
(Crawled : 13:15)
- ir.stockpr.com
CYTH
|
$1.25
2.46%
2.4%
31K
|
Professional, Scientific, and T...
|
-82.57%
|
O:
4.71%
H:
0.0%
C:
-3.96%
financial results
results
Makana Therapeutics Announces the Appointment of Dr. Kurt Dasse to its Board of Directors
Published:
2021-05-17
(Crawled : 13:15)
- biospace.com/
ABT
|
News
|
$105.9
-3.03%
0.07%
12M
|
Health Technology
|
-8.77%
|
O:
-0.26%
H:
0.3%
C:
-1.07%
DiaMedica Therapeutics Announces FDA Clearance of IND Application to Initiate Phase 2/3 Clinical Trial for DM199 for Acute Ischemic Stroke
Published:
2021-05-17
(Crawled : 13:15)
- biospace.com/
DMAC
|
News
|
$2.58
8.86%
8.14%
41K
|
Health Technology
|
-61.92%
|
O:
8.31%
H:
2.27%
C:
-2.7%
fda clearance
fda
stroke
phase 2
phase 2/3
trial
application
clearance
Turning Point Therapeutics Names Kumar Srinivasan as Executive Vice President, Chief Business Officer
Published:
2021-05-17
(Crawled : 13:15)
- globenewswire.com
TPTX
|
$76.01
-0.03%
|
Health Technology
|
9.57%
|
O:
-1.79%
H:
4.76%
C:
3.44%
ESPERION Appoints Sheldon Koenig as President and CEO
Published:
2021-05-17
(Crawled : 13:15)
- globenewswire.com
SNY
|
News
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-12.57%
|
O:
0.59%
H:
1.0%
C:
0.83%
ESPR
|
$1.83
-4.19%
-4.37%
3.7M
|
Health Technology
|
-91.65%
|
O:
-0.74%
H:
0.0%
C:
-8.1%
ceo
leo
Liminal BioSciences Enters into Agreement with Kedrion to Divest Its Plasma Collection and Plasma-Derived Therapeutics Business
Published:
2021-05-17
(Crawled : 13:00)
- biospace.com/
LMNL
|
$8.5
0.12%
0.12%
0
|
Health Technology
|
98.6%
|
O:
1.64%
H:
14.71%
C:
2.07%
F-star Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Update
Published:
2021-05-17
(Crawled : 13:00)
- globenewswire.com
FSTX
|
$7.12
0.0%
0
|
Health Technology
|
8.3%
|
O:
-2.59%
H:
19.53%
C:
5.31%
financial results
results
Galectin Therapeutics Reports Financial Results for the Quarter Ended March 31, 2021, and Provides Business Update
Published:
2021-05-17
(Crawled : 13:00)
- globenewswire.com
GALT
|
$3.4
0.0%
160K
|
Health Technology
|
-20.09%
|
O:
-0.71%
H:
8.81%
C:
4.29%
financial results
results
galectin-3
Summit Therapeutics Reports Financial Results and Operational Progress for the First Quarter Ended March 31, 2021
Published:
2021-05-17
(Crawled : 13:00)
- globenewswire.com
SMMT
A
|
$3.58
1.13%
1.12%
1.4M
|
Health Technology
|
-34.01%
|
O:
11.53%
H:
23.14%
C:
13.52%
financial results
results
Humanigen and Chime Biologics Enter Into Manufacturing Agreement for COVID-19 Therapeutic Candidate Lenzilumab
Published:
2021-05-17
(Crawled : 13:00)
- biospace.com/
HGEN
|
$0.0361
-61.5%
120M
|
Health Technology
|
-99.8%
|
O:
1.41%
H:
4.59%
C:
4.56%
covid
lenzilumab
covid-19
ADC Therapeutics Announces Receipt of $50 Million Second Tranche of Convertible Credit Facility with Deerfield
Published:
2021-05-17
(Crawled : 12:15)
- biospace.com/
ADCT
|
$4.96
11.71%
1.41%
1.2M
|
Health Technology
|
-79.09%
|
O:
0.05%
H:
3.34%
C:
0.85%
← Previous
1
2
Next →
Gainers vs Losers
56%
44%
Top 10 Gainers
INVO
|
$1.76
131.58%
56.82%
230M
|
Health Technology
SINT
|
$0.0365
59.39%
37.26%
470M
|
Health Technology
WISA
4
|
$9.19
50.66%
33.7%
65M
|
Electronic Technology
EDBL
|
News
|
$6.73
47.91%
32.39%
13M
|
GCTK
|
$0.715
36.27%
26.62%
640K
|
Manufacturing
TCON
|
$2.33
36.26%
26.61%
2M
|
Health Technology
TIRX
|
$0.48
6.43%
24.58%
4.8M
|
KZIA
|
$0.38
30.58%
23.42%
300K
|
Health Technology
VNDA
|
News
|
$5.23
29.14%
22.56%
24M
|
Health Technology
ATNF
|
$1.91
29.05%
22.51%
310K
|
Your saved searches
Save your searches and get alerts when important news are released.